#United States #Minneapolis #Bio-Techne #Spyre #COMET Suite

Bio-Techne Expands Spatial Biology Offerings

In a significant leap for the field of spatial biology, Bio-Techne Corporation has launched exciting new additions to its COMET™ solution portfolio. The unveiling, which includes the innovative SPYRE™ Focus Panels and SPYRE™ Amplification Kits, promises to enhance the capabilities of researchers through improved flexibility and sensitivity in data analysis.

The introduction of the SPYRE™ Focus Panels—specifically designed to include Stroma and Vessel modules—marks a new era in modular antibody panel options. These panels are tailored to enable researchers to design multiplex assays with minimal optimization time, leveraging ready-to-use protocols while allowing for personalization with the lab’s existing antibody libraries. Additionally, the SPYRE™ Amplification Kits utilize seqLA™ technology that significantly boosts detection capabilities for low-abundance and hard-to-detect targets.

Steve Crouse, President of Bio-Techne's Diagnostics and Spatial Biology Segment, emphasized the importance of these innovations in modern research. "Researchers need tools that simplify the extraction of meaningful answers from complex tissue samples. With the SPYRE Focus Panels and Amplification Kits, we are providing a faster, more nuanced workflow that empowers researchers to uncover deeper insights with heightened confidence," he stated.

The updates also bring enhancements to the HORIZON™ Image Analysis Software, offering tools specifically designed for analyzing hyperplex images created by the new SPYRE technology. This integration allows for a more streamlined approach to tissue analysis and is expected to facilitate smoother research processes.

One notable endorsement of these advancements comes from Professor Joanne Edwards of the University of Glasgow. She remarked, "Utilizing the pre-optimized SPYRE panel has not only increased the capacity of conventional multiplex immunofluorescence but has also enabled a one-day experimental protocol. The COMET workflow is straightforward and flexible, which allows us to seamlessly incorporate our antibodies of interest into the process. This technology delivers insightful data and facilitates the simultaneous investigation of tumor and microenvironment cells within the same sample."

The strategic enhancement of the COMET spatial biology ecosystem underscores Bio-Techne's commitment to advancing research tools and preclinical therapeutic development. By offering a fully integrated, automated, and modular spatial biology framework, the company is poised to empower researchers and advance understanding of complex biological processes.

As Bio-Techne continues to innovate within the life sciences landscape, its latest offerings demonstrate how technology can redefine research possibilities and catalyze discoveries that enhance our understanding of health and disease. This move not only reflects Bio-Techne's dedication to its research and clinical diagnostic communities but also its goal to sustain quality advancements in scientific exploration and medical breakthroughs.

• ---

About Bio-Techne Corporation

Bio-Techne Corporation, trading under the NASDAQ symbol TECH, stands as a global leader in providing innovative life science tools, reagents, and diagnostic products. Committed to facilitating cutting-edge scientific research, Bio-Techne offers an extensive array of products aimed at unraveling biological processes and improving disease diagnosis and treatment. With over 3,100 employees and net sales surpassing $1.2 billion in fiscal 2025, Bio-Techne remains at the forefront of enhancing laboratory efficiency and accuracy. For additional information, visit www.bio-techne.com or follow the company on social media platforms including LinkedIn, X, and YouTube.